208 filings
Page 5 of 11
8-K
fklkzionq12jk
21 May 21
Departure of Directors or Certain Officers
4:02pm
8-K
xfbkgy3stchmpmye
7 May 21
Elanco Animal Health Reports First Quarter 2021 Results
6:42am
8-K
tzyv5q66xye3e3
7 May 21
Regulation FD Disclosure
6:40am
DEFA14A
cj9g6j
8 Apr 21
Additional proxy soliciting materials
4:29pm
8-K
051cj
24 Feb 21
Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results
6:45am
8-K
6a8c ddzrl24w28hhg4
23 Feb 21
Elanco General Counsel Michael-Bryant Hicks to Depart After Successful Company Stand-Up and Acquisition Completion
12:00am
8-K
7s3v054
26 Jan 21
Elanco Announces Next Wave of Restructuring to Drive Operational Efficiencies Post Bayer Acquisition
8:19am
8-K
taegkdn 8b0k7ie9hy
11 Jan 21
Elanco Begins Next Phase of Integration Post-Bayer Animal Health Acquisition; Executive Committee Member Sarena Lin to Depart
3:20pm
8-K
jgqbluv56v1 l7j50c
17 Dec 20
Other Events
4:40pm
8-K
6ocb4iuxqa
15 Dec 20
Elanco Animal Health Hosts Investor Day, Demonstrating Inflection Point Toward Accelerated Value Creation
8:07am
8-K
o6rrlsjyjxx0t9a
15 Dec 20
Departure of Directors or Certain Officers
6:02am
8-K
luoz50 822
3 Dec 20
Other Events
4:11pm
424B7
d0nlz4 eprlqkcq5
2 Dec 20
Prospectus with selling stockholder info
4:13pm
8-K
kz9lnptoia 0j905o6q
1 Dec 20
Elanco Announces Pricing of Public Offering of Common Stock by Selling Shareholder
6:09am
FWP
dvrgl 6we
30 Nov 20
Free writing prospectus
9:19pm
8-K
wju5qkk8 5ko
30 Nov 20
Elanco Announces Public Offering of Common Stock by Selling Shareholder
7:20am
424B7
ioi8r89ju4d ud5
30 Nov 20
Prospectus with selling stockholder info
7:08am